23484-71-1

Basic information

• Product Name: 1-Oxa-3,8-diazaspiro[4.5]decan-2-one,4-ethyl-(8CI,9CI)
• Synonyms: 1-Oxa-3,8-diazaspiro[4.5]decan-2-one,4-ethyl-(8CI,9CI)
• CAS NO: 23484-71-1
• Molecular Formula: C₉H₁₆N₂O₂
• Molecular Weight: 184.23554
• Product Categories: N-BOC
• Mol File: 23484-71-1.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-Oxa-3,8-diazaspiro[4.5]decan-2-one,4-ethyl-(8CI,9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Oxa-3,8-diazaspiro[4.5]decan-2-one,4-ethyl-(8CI,9CI)(23484-71-1)
• EPA Substance Registry System: 1-Oxa-3,8-diazaspiro[4.5]decan-2-one,4-ethyl-(8CI,9CI)(23484-71-1)

Safety Data

• Hazardous Substances Data: 23484-71-1(Hazardous Substances Data)

Usage

Molecular structure

A complex ring system with a spiro carbocyclic ring system incorporating a nitrogen atom and an oxygen atom.

Functional groups

The presence of a ketone group (C=O) at the 2-one position and the nitrogen atoms contribute to the compound's chemical reactivity.

Ethyl group

The presence of a two-carbon alkyl group (-CH2-CH3) attached to the molecule, which can influence its chemical properties and reactivity.

Potential applications

Possible uses in pharmaceuticals, materials science, and organic synthesis due to its unique structure and functional groups.

Chemical properties

The compound may exhibit diverse chemical properties and reactivity due to its complex structure and functional groups, making it a promising candidate for further study.

Commercial uses

The compound's potential applications and unique properties may lead to its development for commercial use in various industries.

Upstream product

• 23493-81-4 8-benzyl-4-ethyl-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 

Downstream Products

• 23484-93-7 4-ethyl-8-(3-oxo-3-phenyl-propyl)-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 
• 79053-68-2 4-phenyl-8-[2-(3-indolyl)ethyl]-1-oxa-3,8-diazaspiro[4.5]decan-2-one 
• 29122-07-4 4-ethyl-8-(1,2,3,4-tetrahydro-naphthalen-2-yl)-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 
• 38285-10-8 4-ethyl-8-(2-phenoxy-ethyl)-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 
• 29218-08-4 4-ethyl-8-(1-methyl-2-phenyl-ethyl)-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 
• 38285-25-5 8-[2-(2,6-dichloro-phenoxy)-ethyl]-4-ethyl-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 
• 40066-75-9 4-ethyl-8-(2-methyl-4-phenyl-cyclohexyl)-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 
• 38285-21-1 4-ethyl-8-(1-methyl-2-phenoxy-ethyl)-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 
• 29218-17-5 4-ethyl-8-[2-(3-methoxy-phenyl)-1-methyl-ethyl]-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 
• 53491-28-4 8-(4-benzyloxy-cyclohexyl)-4-ethyl-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 
• 53491-26-2 4-ethyl-8-(3-phenoxy-propyl)-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 
• 40212-11-1 4-ethyl-8-(2-phenyl-cyclohexyl)-1-oxa-3,8-diaza-spiro[4.5]decan-2-one 

Relevant articles and documents

SPIROCYCLIC COMPOUNDS AS AGONISTS OF THE MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPTOR

This invention relates to compounds that are agonists of the muscarinic M1 and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula. (I) where p, q, r, s, X, Z, Y, R1, R2, R3and R4 are as defined herein.